跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONTEK CHEWABLE TABLETS 4MG - HSA Drug Approval Details
Approvals
/
HSA
/
MONTEK CHEWABLE TABLETS 4MG
Approved
THERAPEUTIC
MONTEK CHEWABLE TABLETS 4MG
Sun Pharmaceutical Industries Limited
🇸🇬 Health Sciences Authority
Approval Date
Feb 19, 2019
Approval ID
3bfedbbc60259464
Company
Sun Pharmaceutical Industries Limited
Type
Therapeutic
Approval Details
Approval Id
3bfedbbc60259464
Drug Name
MONTEK CHEWABLE TABLETS 4MG
Product Name
MONTEK CHEWABLE TABLETS 4MG
Approval Number
SIN15630P
Approval Date
2019-02-19
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Montelukast Sodium 4.15mg Equivalent to Montelukast
4.00mg
MONTELUKAST SODIUM 4.15 MG EQUIVALENT TO MONTELUKAST
4 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 19, 2019
Approval ID
3bfedbbc60259464
Type
Therapeutic
Back to HSA Approvals